These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15188333

  • 1. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
    Soep JB, Mietus-Snyder M, Malloy MJ, Witztum JL, von Scheven E.
    Arthritis Rheum; 2004 Jun 15; 51(3):451-7. PubMed ID: 15188333
    [Abstract] [Full Text] [Related]

  • 2. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH.
    Arthritis Rheum; 2006 Aug 15; 54(8):2541-9. PubMed ID: 16868975
    [Abstract] [Full Text] [Related]

  • 3. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ.
    Intern Med J; 2006 Apr 15; 36(4):237-43. PubMed ID: 16640741
    [Abstract] [Full Text] [Related]

  • 4. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
    Posadas-Romero C, Torres-Tamayo M, Zamora-González J, Aguilar-Herrera BE, Posadas-Sánchez R, Cardoso-Saldaña G, Ladrón de Guevara G, Solis-Vallejo E, El Hafidi M.
    Arthritis Rheum; 2004 Jan 15; 50(1):160-5. PubMed ID: 14730612
    [Abstract] [Full Text] [Related]

  • 5. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Hörkkö S, Witztum JL.
    Arthritis Rheum; 2005 Jan 15; 52(1):192-200. PubMed ID: 15641060
    [Abstract] [Full Text] [Related]

  • 6. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H.
    Scand J Rheumatol; 2004 Jan 15; 33(4):246-52. PubMed ID: 15370721
    [Abstract] [Full Text] [Related]

  • 7. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov 15; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 8. Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus.
    Sari RA, Polat MF, Taysi S, Bakan E, Capoğlu I.
    Clin Rheumatol; 2002 Nov 15; 21(6):520-4. PubMed ID: 12447639
    [Abstract] [Full Text] [Related]

  • 9. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M, Bodill H, Ahmad Y, Durrington PN, Mackness M, Walker M, Bernstein RM, Bruce IN.
    Circulation; 2004 Jul 27; 110(4):399-404. PubMed ID: 15262847
    [Abstract] [Full Text] [Related]

  • 10. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A, Hennuyer N, Tailleux A, Furman C, Duverger N, Caillaud JM, Castro G, Fievet C, Fruchart JC, Duriez P.
    Clin Sci (Lond); 2001 Mar 27; 100(3):343-55. PubMed ID: 11222122
    [Abstract] [Full Text] [Related]

  • 11. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
    Yassin LM, Londoño J, Montoya G, De Sanctis JB, Rojas M, Ramírez LA, García LF, Vásquez G.
    Autoimmunity; 2011 May 27; 44(3):201-10. PubMed ID: 21231894
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep 27; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 13. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun 27; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 14. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM, Maaty A, Kalil FA.
    Arch Pathol Lab Med; 2011 Nov 27; 135(11):1482-5. PubMed ID: 22032577
    [Abstract] [Full Text] [Related]

  • 15. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
    Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado Alves J.
    Rheumatology (Oxford); 2009 Jan 27; 48(1):26-31. PubMed ID: 19000993
    [Abstract] [Full Text] [Related]

  • 16. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB, Giles IP, Rahman A.
    Lupus; 2011 Jan 27; 20(1):5-13. PubMed ID: 21138982
    [Abstract] [Full Text] [Related]

  • 17. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T, Beyenne J, Feldman B, Adeli K, Silverman E.
    Arthritis Rheum; 2006 Apr 27; 54(4):1283-90. PubMed ID: 16575849
    [Abstract] [Full Text] [Related]

  • 18. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 19. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
    Urquizu-Padilla M, Balada E, Chacon P, Pérez EH, Vilardell-Tarrés M, Ordi-Ros J.
    J Rheumatol; 2009 Aug 09; 36(8):1639-45. PubMed ID: 19531751
    [Abstract] [Full Text] [Related]

  • 20. Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies.
    Gómez-Zumaquero JM, Tinahones FJ, De Ramón E, Camps M, Garrido L, Soriguer FJ.
    Rheumatology (Oxford); 2004 Apr 09; 43(4):510-3. PubMed ID: 14872100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.